✦ LIBER ✦

Vasopressin therapy in Parkinson's disease

✍ Scribed by John P. A. Jensen

Book ID: 114781005
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 141 KB
Volume: 62
Category: Article
ISSN: 0001-6314
DOI: 10.1111/j.1600-0404.1980.tb03024.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Extrahypothalamic vasopressin is unchang

Extrahypothalamic vasopressin is unchanged in Parkinson's disease and Huntington's disease

✍ M.N. Rossor; S.P. Hunt; L.L. Iversen; R. Bannister; J. Hawthorn; V.T.Y. Ang; J.S 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 288 KB

Transdermal therapy in Parkinson's disea

Transdermal therapy in Parkinson's disease

✍ Amos D Korczyn 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 44 KB

Gene therapy in Parkinson’s disease

✍ O. Eberhardt; J. B. Schulz 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 274 KB

Pergolide therapy in parkinson's disease

✍ P. Jeanty; M. Kerchove; A. Lowenthal; H. Bruyne 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 543 KB

A total of 26 patients were treated with pergolide mesylate, a semi-synthetic ergot derivative with the property of direct dopamine activity. Of these patients, 18 suffered from late failure of L-dopa, while the remaining 8 had never before been treated with L-dopa. The aim of the trial was to study

Initiating therapy in Parkinson's diseas

Initiating therapy in Parkinson's disease

✍ William Weiner; Eric Ahlskog; Stewart Factor; Oksana Suchowersky; Stephen Reich 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB 👁 2 views

Speech therapy in Parkinson's disease

📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB